The clinical continuum of cryopyrinopathies: Novel CIAS1 mutations in North American patients and a new cryopyrin model-Reference-Cited by-同舟云学术

The clinical continuum of cryopyrinopathies: Novel CIAS1 mutations in North American patients and a new cryopyrin model

Published:2007 Issue:4 Volume:56 Page:1273-1285
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Aksentijevich Ivona,D. Putnam Christopher,Remmers Elaine F.,Mueller James L.,Le Julie,Kolodner Richard D.,Moak Zachary,Chuang Michael,Austin Frances,Goldbach-Mansky Raphaela,Hoffman Hal M.,Kastner Daniel L.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference54 articles.

1. Familial autoinflammatory diseases: genetics, pathogenesis and treatment

2. A Chronic, Infantile, Neurological, Cutaneous and Articular (CINCA) Syndrome. A Specific Entity Analysed in 30 Patients

3. Association of mutations in theNALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis

4. New Mutations of CIAS1 That Are Responsible for Muckle-Wells Syndrome and Familial Cold Urticaria: A Novel Mutation Underlies Both Syndromes

5. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome

Cited by 344 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mast cell activation syndrome: Current understanding and research needs;Journal of Allergy and Clinical Immunology;2024-08

2. 38.3 Primary Immunodeficiencies: When is it not just “JIA”;Best Practice & Research Clinical Rheumatology;2024-06

3. Die häufigsten Fiebersyndrome und autoinflammatorischen Erkrankungen im Erwachsenenalter;Zeitschrift für Rheumatologie;2024-05-27

4. Mosaïcisme génétique dans les maladies auto-inflammatoires : revue de la littérature;La Revue de Médecine Interne;2024-05

5. Practical Approach to Diagnosis and Management of IL-1-Mediated Autoinflammatory Diseases (CAPS, TRAPS, MKD, and DIRA);Pediatric Drugs;2024-02-20